Skip to main content

Fluidigm Inks Singapore, Thailand Distribution Pact

NEW YORK (GenomeWeb News) – Fluidigm has appointed Research Instruments Pte/RI Technologies as its distributor in Singapore and Thailand.

Under the alliance, Research Instruments will offer Fluidigm's portfolio of BioMark HD, EP1, and Access Array Systems. Financial and other terms of the agreement were not disclosed.

Greg Kent, CEO of Research Instruments, said in a statement that the deal "fits perfectly with our efforts to enable our customers with next-generation genomics technology in Singapore and Thailand."

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.